Literature DB >> 24166866

Vitamin D does not increase calcium absorption in young women: a randomized clinical trial.

J Christopher Gallagher1, Prachi S Jindal, Lynette M Smith.   

Abstract

It is commonly said that vitamin D should be used to increase calcium absorption. We tested this statement in a dose-response study of vitamin D on calcium absorption. A total of 198 white and African American women, aged 25 to 45 years, with vitamin D insufficiency, serum 25-hydroxyvitamin D (25OHD) <20 ng/mL, were randomized in a double-blind study to vitamin D3 400, 800, 1600, 2400 IU, or placebo. A calcium supplement was given to increase mean calcium intake at baseline from 706 mg/d to 1031 mg/d. Calcium absorption was measured at baseline and after 12 months using a single isotope method with radiocalcium45 and 100 mg of calcium. Mean baseline serum 25OHD was 13.4 ng/mL (33.5 nmol/L) and increased to 40 ng/mL (100 nmol/L) on the highest dose of 2400 IU. Using a multivariate regression analysis with significant predictors, baseline absorption, calcium intake, and weight, there was no increase in 12-month calcium absorption compared with baseline on any dose of vitamin D in either whites or African Americans. There was no significant relationship between 12-month calcium absorption and final serum 25OHD. In an analysis of calcium absorption and serum 25OHD at baseline, serum 25OHD levels were divided into groups: 0 to 5, 6 to 10, 11 to 15, or 16 to 20 ng/mL. There was no evidence of a threshold decrease in calcium absorption or serum 1,25 dihydroxyvitamin D (1,25(OH)2 D) amongst the lowest groups. Vitamin D doses up to 2400 IU daily did not increase calcium absorption. No threshold level of serum 25OHD for calcium absorption was found at baseline or in the longitudinal study, suggesting that active transport of calcium is saturated at very low serum 25OHD levels <5 ng/mL. There is no need to recommend vitamin D for increasing calcium absorption in normal subjects. Very efficient calcium absorption at very low levels of serum 25OHD explains why people do not develop osteomalacia provided that dietary intakes of calcium and phosphorus are adequate.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  1,25(OH)2D; 25OHD; CALCIUM ABSORPTION; VITAMIN D

Mesh:

Substances:

Year:  2014        PMID: 24166866     DOI: 10.1002/jbmr.2121

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

Review 1.  Dietary Vitamin D Intake for the Elderly Population: Update on the Recommended Dietary Allowance for Vitamin D.

Authors:  Lynette M Smith; J Christopher Gallagher
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

2.  Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations.

Authors:  Janice B Schwartz; J Christopher Gallagher; Rolf Jorde; Vivian Berg; Jennifer Walsh; Richard Eastell; Amy L Evans; Simon Bowles; Kim E Naylor; Kerry S Jones; Inez Schoenmakers; Michael Holick; Eric Orwoll; Carrie Nielson; Martin Kaufmann; Glenville Jones; Roger Bouillon; Jennifer Lai; Davide Verotta; Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2018-09-01       Impact factor: 5.958

Review 3.  Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?

Authors:  I R Reid; M J Bolland
Journal:  Osteoporos Int       Date:  2014-05-21       Impact factor: 4.507

4.  Normal bone mass and normocalcemia in adulthood despite homozygous vitamin D receptor mutations.

Authors:  F M Damiani; R M Martin; A C Latronico; B Ferraz-de-Souza
Journal:  Osteoporos Int       Date:  2015-02-24       Impact factor: 4.507

5.  Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women.

Authors:  John Christopher Gallagher; Lynette M Smith; Vinod Yalamanchili
Journal:  Menopause       Date:  2014-11       Impact factor: 2.953

6.  Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.

Authors:  M Li; F Lv; Z Zhang; W Deng; Y Li; Z Deng; Y Jiang; O Wang; X Xing; L Xu; W Xia
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

7.  The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers.

Authors:  John Paul Ekwaru; Jennifer D Zwicker; Michael F Holick; Edward Giovannucci; Paul J Veugelers
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

8.  Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women.

Authors:  L M Smith; J C Gallagher
Journal:  Osteoporos Int       Date:  2020-09-04       Impact factor: 4.507

9.  Dose and time responses of vitamin D biomarkers to monthly vitamin D3 supplementation in overweight/obese African Americans with suboptimal vitamin d status: a placebo controlled randomized clinical trial.

Authors:  Jigar Bhagatwala; Haidong Zhu; Samip J Parikh; De-Huang Guo; Ishita Kotak; Ying Huang; Robyn Havens; Michael Pham; Eric Afari; Susan Kim; Christopher Cutler; Norman K Pollock; Yutong Dong; Anas Raed; Yanbin Dong
Journal:  BMC Obes       Date:  2015-07-04

10.  Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study.

Authors:  Yukio Nakamura; Mikio Kamimura; Shota Ikegami; Keijiro Mukaiyama; Shigeharu Uchiyama; Akira Taguchi; Hiroyuki Kato
Journal:  BMC Endocr Disord       Date:  2015-12-15       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.